We are glad to announce you that the continuation of the EUROMAC registry is ensured for the next 3 years through funding obtained at two Spanish national calls.

In this project Dr Ros Quinlivan at University College London will lead an international clinical trial to test, for the first time, the safety and effectiveness of a drug (Sodium Valproate) for McArdle disease. Work carried out in animal models suggests the drug may have a beneficial effect for people with this condition.

Dr. Ramon Martí, head of the Laboratory for Mitochondrial Disorders at Barcelona’s Vall D´Hebron Research Institute is the coordinator of the EUROMAC project.

EUROMAC registry is a secure, anonimised and confidential database designed to contain the medical data related to people with McArdle Disease and related conditions who give their consent to inclusion.

Check out the views and feelings from patients affected by McArdle’s Diseases and other other forms of rare neuromuscular glycogenosis, where exercise intolerance is the main symptom.